MerLion scores a first for S'pore with FDA approval of its ear infection drug
Singapore
BIOPHARMACEUTICAL company MerLion Pharmaceuticals is the first homegrown company to have its new novel drug approved by the United States Food and Drug Administration (FDA), paving the way for it to be commercially available to treat ear infections.
This follows Phase 3 trials of finafloxacin otic suspension in treating acute otitis externa, which is an infection in the outer ear and ear canal and is commonly known as "swimmer's ear".
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
Meta’s results are best viewed through rose-tinted AI glasses
'Harvesting data': Latin American AI startups transform farming
After long peace, Big Tech faces US antitrust reckoning
Tech’s cash crunch sees creditors turn ‘violent’ with one another
Tech millionaires chase billionaire tax shields with ‘swap fund’
Elon Musk’s Starlink profits are more elusive than investors think